UK markets close in 3 hours 41 minutes

Fate Therapeutics, Inc. (FATE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.5400+0.0200 (+0.57%)
At close: 04:00PM EDT
3.5400 0.00 (0.00%)
Pre-market: 07:16AM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
41,870
61,333
133,583
167,347
-
Other short-term investments
273,305
374,894
482,327
315,569
-
Total cash
315,175
436,227
615,910
482,916
-
Net receivables
1,826
38,480
8,676
5,515
-
Other current assets
14,539
27,367
8,826
-
-
Total current assets
331,540
502,074
633,412
494,323
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
206,137
206,473
179,194
110,487
-
Accumulated depreciation
-47,626
-30,384
-16,945
-11,095
-
Net property, plant and equipment
158,511
176,089
162,249
99,392
-
Equity and other investments
980
4,942
100,664
0
-
Other long-term assets
15,186
15,260
15,260
15,236
-
Total non-current assets
174,677
203,487
288,043
128,134
-
Total assets
506,217
705,561
921,455
622,457
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
4,719
8,265
8,612
6,283
-
Accrued liabilities
27,514
53,932
42,412
15,564
-
Deferred revenues
685
42,226
21,483
21,144
-
Other current liabilities
-
4,000
3,200
39,218
2,808
Total current liabilities
39,094
114,051
81,284
85,564
-
Non-current liabilities
Deferred revenues
-
0
27,124
46,021
3,775
Other long-term liabilities
-
-
800
800
702
Total non-current liabilities
98,706
107,571
161,333
152,448
-
Total liabilities
137,800
221,622
242,617
238,012
-
Stockholders' equity
Common stock
102
100
99
91
-
Retained earnings
-1,211,732
-1,050,804
-769,083
-556,932
-
Accumulated other comprehensive income
15
-1,854
-762
70
-
Total stockholders' equity
368,417
483,939
678,838
384,445
-
Total liabilities and stockholders' equity
506,217
705,561
921,455
622,457
-